Is so, long price target is what?
FDA Approved! There is a reason! It's SAFE & EFFECTIVE!
This is a event based emotional upside down gap. CMS, US Commercial launch etc. fills and AND retest highs in high teens
2 GAPS - the 2/12/16 gap at $6.55, and the 3/1/16 GAP at $9. Gap 1 fills today, the second at $9 provides nearly 50% UPSIDE. GOOD LUCK TRADING GAPS!
◾If a stock gaps down after a wave of selling has already occurred, these are amateurs selling the stock - look to go long.
So what’s that mean: when a stock price gap is observed, by a chance of 91.4% it will get filled in the future. In layman’s word, 9 in 10 gaps get filled; not always, but pretty close.
CONCLUSION: I WILL GO WITH THE 91% PLUS ODDS THAT THIS GAP GETS FILLED AT SOME POINT. JUST SAYIN'
Sentiment: Strong Buy
I would doubt it is Fresenius as well as Stifel & Oppenheimer have only confirmed pilots at Davita. However, Fresenius did take part in the Cruise 1 & 2 studies and as their competitive contractual obligation nears an end (I think 2017), Triferic may be a consideration as part of the CMS bundle payment. If, in fact, if ESA sparing can be achieved , even at single digit levels, Fresenius would lose significant market share in an already thin margin business, if they don't get on board with Triferic, especially when patient advocacy groups will push to do "less harm" to patients
No delay like KERX was hoping for. HOPE is Not a Strategy. KERX and his nefarious camarilla are trying to SCAM innocent investors out of money by FEAR Mongering.